Compare Baxter International Inc (BAX) vs Eli Lilly And Co (LLY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Baxter International Inc vs Eli Lilly And Co — how do they compare? Baxter International Inc trades at $27.61 (market cap $14.36B), while Eli Lilly And Co trades at $1,215 (market cap $1.10T). The key difference: Eli Lilly And Co is far larger — about 76.6× Baxter International Inc's market cap, and Eli Lilly And Co pays the higher dividend (0.56%). Which is the better fit depends on your goals.
| BAX | LLY | |
|---|---|---|
Market Cap | $14.36B | $1.10T |
Sector | Health | Health |
52-Week High | $28.35 | $1.24K |
52-Week Low | $15.80 | $639.43 |
Enterprise Value | $21.88B | $1.14T |
Dividend Yield | 0.14% | 0.56% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Baxter International Inc
Baxter offers a variety of medical instruments and supplies to caregivers. It enhanced its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021. Legacy Baxter offers tools to help patients with acute and chronic kidney failure. It also sells a variety of injectable therapies for use in care settings, such as IV pumps, and administrative sets.
Read more on BAX →About Eli Lilly And Co
Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer
Read more on LLY →
